These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 3563966

  • 1. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A, Krachmalnicoff A, Mannucci PM.
    Thromb Haemost; 1986 Dec 15; 56(3):349-52. PubMed ID: 3563966
    [Abstract] [Full Text] [Related]

  • 2. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M, Petersen LC, Thorsen S.
    J Lab Clin Med; 1984 Aug 15; 104(2):245-56. PubMed ID: 6747440
    [Abstract] [Full Text] [Related]

  • 3. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K, Ueyama H, Hashimoto Y, Sasaki Y, Matsumoto K, Okabe H, Inoue M, Araki S, Takatsuki K.
    Thromb Haemost; 1989 Feb 28; 61(1):20-4. PubMed ID: 2749590
    [Abstract] [Full Text] [Related]

  • 4. Homozygous variant of antithrombin III: AT III Fontainebleau.
    Boyer C, Wolf M, Vedrenne J, Meyer D, Larrieu MJ.
    Thromb Haemost; 1986 Aug 20; 56(1):18-22. PubMed ID: 3775688
    [Abstract] [Full Text] [Related]

  • 5. Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville.
    Aiach M, Roncato M, Chadeuf G, Dezellus P, Capron L, Fiessinger JN.
    Thromb Haemost; 1988 Aug 30; 60(1):94-6. PubMed ID: 3187951
    [Abstract] [Full Text] [Related]

  • 6. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
    de Moerloose PA, Reber G, Vernet P, Minazio P, Bouvier CA.
    Thromb Haemost; 1987 Apr 07; 57(2):154-7. PubMed ID: 3603409
    [Abstract] [Full Text] [Related]

  • 7. Antithrombin III Alger: a new homozygous AT III variant.
    Fischer AM, Cornu P, Sternberg C, Mériane F, Dautzenberg MD, Chafa O, Beguin S, Desnos M.
    Thromb Haemost; 1986 Apr 30; 55(2):218-21. PubMed ID: 3715788
    [Abstract] [Full Text] [Related]

  • 8. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
    Wolf M, Boyer-Neumann C, Meyer D, Tripodi A, Mannucci PM, Larrieu MJ.
    Thromb Haemost; 1987 Oct 28; 58(3):888-92. PubMed ID: 3433251
    [Abstract] [Full Text] [Related]

  • 9. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE.
    J Clin Invest; 1986 Mar 28; 77(3):887-93. PubMed ID: 3512602
    [Abstract] [Full Text] [Related]

  • 10. Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa.
    Austin RC, Rachubinski RA, Ofosu FA, Blajchman MA.
    Blood; 1991 May 15; 77(10):2185-9. PubMed ID: 2029579
    [Abstract] [Full Text] [Related]

  • 11. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G, Blaskó G, Bánhegyi D, Jákó J, Pálos LA.
    Thromb Diath Haemorrh; 1974 Sep 30; 32(1):105-15. PubMed ID: 4454033
    [Abstract] [Full Text] [Related]

  • 12. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ, Samson D, Stirling Y, Seghatchian MJ.
    Thromb Haemost; 1985 Jun 24; 53(3):314-9. PubMed ID: 4049307
    [Abstract] [Full Text] [Related]

  • 13. Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusing.
    Leone G, De Stefano V, Ferrelli R, Teofili L, Tengborn L, Vahtera E, Bizzi B.
    Thromb Haemost; 1988 Aug 30; 60(1):8-12. PubMed ID: 3187949
    [Abstract] [Full Text] [Related]

  • 14. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E.
    Br J Haematol; 1981 Jun 30; 48(2):325-36. PubMed ID: 7236529
    [Abstract] [Full Text] [Related]

  • 15. The interaction of immobilized thrombin with human antithrombin III.
    Marciniak E, Gora-Maslak G.
    Thromb Haemost; 1984 Feb 28; 51(1):27-31. PubMed ID: 6719385
    [Abstract] [Full Text] [Related]

  • 16. Homozygous or compound heterozygous qualitative antithrombin III deficiency.
    Cucuianu M, Blaga S, Pop S, Olinic D, Olinic N, Colhon D, Cristea A.
    Nouv Rev Fr Hematol (1978); 1994 Aug 28; 36(4):335-7. PubMed ID: 7971256
    [Abstract] [Full Text] [Related]

  • 17. Microheterogeneity of antithrombin III: effect of single amino acid substitutions and relationship with functional abnormalities.
    De Stefano V, Leone G, Mastrangelo S, Lane DA, Girolami A, de Moerloose P, Sas G, Abildgaard U, Blajchman M, Rodeghiero F.
    Blood Coagul Fibrinolysis; 1994 Feb 28; 5(1):7-15. PubMed ID: 8180341
    [Abstract] [Full Text] [Related]

  • 18. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
    Grau E, Fontcuberta J, Félez J, de Diego I, Soto R, Rutllant ML.
    Thromb Haemost; 1988 Feb 25; 59(1):13-7. PubMed ID: 3363529
    [Abstract] [Full Text] [Related]

  • 19. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM, Hathaway WE, Reeve EB, Leonard BD.
    Thromb Haemost; 1982 Feb 26; 47(1):56-8. PubMed ID: 7071806
    [Abstract] [Full Text] [Related]

  • 20. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
    Okajima K, Abe H, Wagatsuma M, Okabe H, Takatsuki K.
    Am J Hematol; 1995 Jan 26; 48(1):12-8. PubMed ID: 7832187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.